Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Ovarian Neoplasms"" wg kryterium: Temat


Tytuł :
A Simple, Novel Prognostic Score in Platinum Sensitive Relapsed Ovarian Cancer.
Autorzy :
Goenka L; Departments of Medical Oncology.
Nakka T; Departments of Medical Oncology.
Dubashi B; Departments of Medical Oncology.
Kayal S; Departments of Medical Oncology.
Penumadu P; Surgical Oncology.
Chaturvedula L; Obstetrics and Gynecology, JIPMER, Puducherry, India.
Veena P; Obstetrics and Gynecology, JIPMER, Puducherry, India.
Durairaj J; Obstetrics and Gynecology, JIPMER, Puducherry, India.
Ganesan P; Departments of Medical Oncology.
Pokaż więcej
Źródło :
American journal of clinical oncology [Am J Clin Oncol] 2021 Aug 01; Vol. 44 (8), pp. 434-441.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carcinoma, Ovarian Epithelial/*drug therapy
Carcinoma, Ovarian Epithelial/*pathology
Ovarian Neoplasms/*drug therapy
Ovarian Neoplasms/*pathology
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carcinoma, Ovarian Epithelial/mortality ; Carcinoma, Ovarian Epithelial/surgery ; Female ; Humans ; Lymphocyte Count ; Middle Aged ; Monocytes ; Neoplasm Recurrence, Local ; Ovarian Neoplasms/mortality ; Ovarian Neoplasms/surgery ; Platinum Compounds/adverse effects ; Platinum Compounds/therapeutic use ; Prognosis ; Progression-Free Survival ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Risk of epithelial ovarian cancer Type I and II after hysterectomy, salpingectomy and tubal ligation-A nationwide case-control study.
Autorzy :
Darelius A; Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Gynecology and Reproductive Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Kristjansdottir B; Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Gynecology and Reproductive Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Dahm-Kähler P; Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Gynecology and Reproductive Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Strandell A; Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Gynecology and Reproductive Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 15; Vol. 149 (8), pp. 1544-1552. Date of Electronic Publication: 2021 Jul 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Ovarian Epithelial/*pathology
Hysterectomy/*adverse effects
Ovarian Neoplasms/*pathology
Salpingectomy/*adverse effects
Sterilization, Tubal/*adverse effects
Aged ; Carcinoma, Ovarian Epithelial/classification ; Carcinoma, Ovarian Epithelial/etiology ; Case-Control Studies ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Ovarian Neoplasms/classification ; Ovarian Neoplasms/etiology ; Prognosis ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
Clinico-pathological Evaluation of Residual Ovary Syndrome: A Cross Sectional Study.
Autorzy :
Nahar K; Dr Khairun Nahar, Associate Professor, Department of Obstetrics and Gynecology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh; E-mail: .
Amatullah M
Khatun K
Laila TR
Pervin T
Begum SA
Pokaż więcej
Źródło :
Mymensingh medical journal : MMJ [Mymensingh Med J] 2021 Oct; Vol. 30 (4), pp. 997-1002.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Ovarian Cysts*
Ovarian Neoplasms*/diagnosis
Ovarian Neoplasms*/epidemiology
Ovarian Neoplasms*/surgery
Adult ; Cross-Sectional Studies ; Female ; Humans ; Hysterectomy ; Middle Aged ; Pregnancy
Czasopismo naukowe
Tytuł :
Diffusion-weighted MRI and PET/CT reproducibility in epithelial ovarian cancers during neoadjuvant chemotherapy.
Autorzy :
Crombé A; Department of Oncologic Imaging, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France; Bordeaux University, 33000 Bordeaux, France; Modelisation in Oncology (MOnc) Team, INRIA Bordeaux-Sud-Ouest, CNRS UMR 5251, 33405, Talence, France. Electronic address: .
Gauquelin L; Department of Biostatistics, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France.
Nougaret S; Department of Radiology, Montpellier Cancer Institute, University of Montpellier, 34090 Montpellier, France.
Chicart M; Department of nuclear medicine, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France.
Pulido M; Department of Biostatistics, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France.
Floquet A; Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France.
Guyon F; Department of Oncological Surgery, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France.
Croce S; Department of Pathology, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France.
Kind M; Department of Oncologic Imaging, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France.
Cazeau AL; Department of nuclear medicine, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France.
Pokaż więcej
Źródło :
Diagnostic and interventional imaging [Diagn Interv Imaging] 2021 Oct; Vol. 102 (10), pp. 629-639. Date of Electronic Publication: 2021 Jun 07.
Typ publikacji :
Clinical Trial; Journal Article
MeSH Terms :
Ovarian Neoplasms*/diagnostic imaging
Ovarian Neoplasms*/drug therapy
Positron Emission Tomography Computed Tomography*
Adult ; Aged ; Carcinoma, Ovarian Epithelial/diagnostic imaging ; Carcinoma, Ovarian Epithelial/drug therapy ; Diffusion Magnetic Resonance Imaging ; Female ; Humans ; Middle Aged ; Neoadjuvant Therapy ; Positron-Emission Tomography ; Prospective Studies ; Radiopharmaceuticals ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
Noninvasive prediction of residual disease for advanced high-grade serous ovarian carcinoma by MRI-based radiomic-clinical nomogram.
Autorzy :
Li H; Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Zhang R; Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China.
Li R; Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Xia W; Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China.
Chen X; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Department of Gynecological Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Zhang J; Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China.
Cai S; Department of Diagnostic Radiology, Shanghai Zhongshan Hospital, Shanghai Medical College of Fudan University, Shanghai, 200032, China.
Li Y; Department of Radiology, Jinshan Hospital, Fudan University, Shanghai, 201508, China.
Zhao S; Department of Radiology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China.
Qiang J; Department of Radiology, Jinshan Hospital, Fudan University, Shanghai, 201508, China.
Peng W; Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Gu Y; Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. .; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. .
Gao X; Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China. .; Department of Radiology, Shanxi Province Cancer Hospital, Shanxi Medical University, Taiyuan, 030013, China. .
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2021 Oct; Vol. 31 (10), pp. 7855-7864. Date of Electronic Publication: 2021 Apr 16.
Typ publikacji :
Journal Article
MeSH Terms :
Nomograms*
Ovarian Neoplasms*/diagnostic imaging
Female ; Humans ; Lymphatic Metastasis ; Magnetic Resonance Imaging ; Neoplasm, Residual/diagnostic imaging ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Detection and prognostic significance of isolated tumor cells and micrometastases in pelvic lymph nodes of patients with early ovarian clear cell carcinoma.
Autorzy :
Wang YC; Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital Linkou Medical Center and Chang Gung University, College of Medicine, Taoyuan, Taiwan; Gynecologic Cancer Research Center, Chang Gung Memorial Hospital Linkou Medical Center, Taoyuan, Taiwan; Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Keelung Branch, Keelung, Taiwan.
Wu RC; Gynecologic Cancer Research Center, Chang Gung Memorial Hospital Linkou Medical Center, Taoyuan, Taiwan; Department of Pathology, Chang Gung Memorial Hospital Linkou Medical Center and Chang Gung University, College of Medicine, Taoyuan, Taiwan.
Jung SM; Gynecologic Cancer Research Center, Chang Gung Memorial Hospital Linkou Medical Center, Taoyuan, Taiwan; Department of Pathology, Chang Gung Memorial Hospital Linkou Medical Center and Chang Gung University, College of Medicine, Taoyuan, Taiwan.
Hao Lin; Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Kaohsiung Branch, Kaohsiung, Taiwan.
Yang LY; Biostatistics Unit, Clinical Trial Center, Chang Gung Memorial Hospital Linkou Medical Center, Taoyuan, Taiwan.
Chao AS; Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital Linkou Medical Center and Chang Gung University, College of Medicine, Taoyuan, Taiwan; Department of Obstetrics and Gynecology, New Taipei City Municipal Tucheng Hospital, New Taipei City, Taiwan.
Chao A; Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital Linkou Medical Center and Chang Gung University, College of Medicine, Taoyuan, Taiwan; Gynecologic Cancer Research Center, Chang Gung Memorial Hospital Linkou Medical Center, Taoyuan, Taiwan. Electronic address: .
Lai CH; Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital Linkou Medical Center and Chang Gung University, College of Medicine, Taoyuan, Taiwan; Gynecologic Cancer Research Center, Chang Gung Memorial Hospital Linkou Medical Center, Taoyuan, Taiwan. Electronic address: .
Pokaż więcej
Źródło :
Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2021 Oct; Vol. 120 (10), pp. 1869-1875. Date of Electronic Publication: 2021 Apr 18.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma, Clear Cell*/diagnosis
Adenocarcinoma, Clear Cell*/pathology
Neoplasm Micrometastasis*
Ovarian Neoplasms*/diagnosis
Ovarian Neoplasms*/pathology
Female ; Humans ; Keratins ; Lymph Nodes ; Lymphatic Metastasis ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Prognosis
Czasopismo naukowe
Tytuł :
Chemotherapy for ovarian cancer during pregnancy: A systematic review and meta-analysis of case reports and series.
Autorzy :
Jiang X; Department of Obstetrics and Gynecology, Ningbo Huamei Hospital, University of Chinese Academy of Sciences, Ningbo, China.
Ye Z; Department of Obstetrics and Gynecology, Ningbo Huamei Hospital, University of Chinese Academy of Sciences, Ningbo, China.
Yu W; Department of Obstetrics and Gynecology, Ningbo Huamei Hospital, University of Chinese Academy of Sciences, Ningbo, China.
Fang Q; Department of Obstetrics and Gynecology, Ningbo Huamei Hospital, University of Chinese Academy of Sciences, Ningbo, China.
Jiang Y; Department of Obstetrics and Gynecology, Ningbo Huamei Hospital, University of Chinese Academy of Sciences, Ningbo, China.; Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, China.
Pokaż więcej
Źródło :
The journal of obstetrics and gynaecology research [J Obstet Gynaecol Res] 2021 Oct; Vol. 47 (10), pp. 3425-3436. Date of Electronic Publication: 2021 Aug 02.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Neoplasm Recurrence, Local*/drug therapy
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/pathology
Antineoplastic Combined Chemotherapy Protocols ; Carboplatin/therapeutic use ; Carcinoma, Ovarian Epithelial ; Cisplatin/therapeutic use ; Disease-Free Survival ; Female ; Humans ; Infant, Newborn ; Neoplasm Staging ; Pregnancy
Czasopismo naukowe
Tytuł :
Disease Distribution at Presentation Impacts Benefit of IP Chemotherapy Among Patients with Advanced-Stage Ovarian Cancer.
Autorzy :
Manning-Geist BL; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St., Boston, MA, 02115, USA. .; Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. .
Sullivan MW; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St., Boston, MA, 02115, USA.; Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Sarda V; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St., Boston, MA, 02115, USA.
Gockley AA; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St., Boston, MA, 02115, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.
Del Carmen MG; Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Matulonis U; Dana-Farber Cancer Institute, Boston, MA, USA.
Growdon WB; Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Horowitz NS; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St., Boston, MA, 02115, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.
Berkowitz RS; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St., Boston, MA, 02115, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.
Clark RM; Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Worley MJ Jr; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St., Boston, MA, 02115, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.
Pokaż więcej
Źródło :
Annals of surgical oncology [Ann Surg Oncol] 2021 Oct; Vol. 28 (11), pp. 6705-6713. Date of Electronic Publication: 2021 Mar 08.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols*/therapeutic use
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/pathology
Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/pathology ; Chemotherapy, Adjuvant ; Cytoreduction Surgical Procedures ; Disease-Free Survival ; Female ; Humans ; Infusions, Parenteral ; Neoplasm Staging ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Loss of Krüppel-like factor 9 facilitates stemness in ovarian cancer ascites-derived multicellular spheroids via Notch1/slug signaling.
Autorzy :
Wang K; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Ji'nan, China.
Liu S; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Ji'nan, China.
Dou Z; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Ji'nan, China.
Zhang S; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Ji'nan, China.
Yang X; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Ji'nan, China.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Oct; Vol. 112 (10), pp. 4220-4233. Date of Electronic Publication: 2021 Aug 20.
Typ publikacji :
Journal Article
MeSH Terms :
Ascites/*pathology
Kruppel-Like Transcription Factors/*metabolism
Neoplastic Stem Cells/*pathology
Ovarian Neoplasms/*pathology
Receptor, Notch1/*metabolism
Snail Family Transcription Factors/*metabolism
Spheroids, Cellular/*pathology
Cell Line, Tumor ; Cell Movement ; Down-Regulation ; Epithelial-Mesenchymal Transition/physiology ; Female ; Humans ; Hyaluronan Receptors/metabolism ; Kruppel-Like Transcription Factors/physiology ; Neoplasm Grading ; Neoplastic Stem Cells/cytology ; Neoplastic Stem Cells/metabolism ; Ovarian Neoplasms/metabolism ; Ovarian Neoplasms/mortality ; Prognosis ; Promoter Regions, Genetic ; Proto-Oncogene Proteins c-kit/metabolism ; Signal Transduction ; Spheroids, Cellular/metabolism
Czasopismo naukowe
Tytuł :
Brenner Borderline Ovarian Tumor: A Case Series and Literature Review.
Autorzy :
Ricotta G; Department of Gynaecologic Surgery, Gustave-Roussy, Villejuif, France.
Maulard A; Department of Gynaecologic Surgery, Gustave-Roussy, Villejuif, France.
Genestie C; Department of Pathology, Gustave-Roussy, Villejuif, France.
Pautier P; Department of Medical Oncology, Gustave-Roussy, Villejuif, France.
Leary A; Department of Medical Oncology, Gustave-Roussy, Villejuif, France.
Chargari C; Department of Radiation Oncology, Gustave-Roussy, Villejuif, France.
Candiani M; IRCCS San Raffaele Hospital, Vita-Salute University, Milan, Italy.
Morice P; Department of Gynaecologic Surgery, Gustave-Roussy, Villejuif, France. .; Paris Sud University, Kremlin Bicetre, France. .
Gouy S; Department of Gynaecologic Surgery, Gustave-Roussy, Villejuif, France.
Pokaż więcej
Źródło :
Annals of surgical oncology [Ann Surg Oncol] 2021 Oct; Vol. 28 (11), pp. 6714-6720. Date of Electronic Publication: 2021 Mar 25.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Neoplasms, Glandular and Epithelial*
Ovarian Neoplasms*/pathology
Ovarian Neoplasms*/surgery
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: a study of the Italian NGS Network.
Autorzy :
Fumagalli C; Unit of Histopathology and Molecular Diagnostics, Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Guerini-Rocco E; Unit of Histopathology and Molecular Diagnostics, Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Buttitta F; Laboratory of Diagnostic Molecular Oncology, Center for Advanced Studies and Technology (CAST), University of Chieti, Chieti, Italy.; Department of Medical and Oral Sciences and Biotechnologies, University of Chieti, Chieti, Italy.
Iapicca P; SOPHiA GENETICS SA, Headquarters, Saint Sulpice, Switzerland.
You W; SOPHiA GENETICS SA, Headquarters, Saint Sulpice, Switzerland.
Mauri M; SOPHiA GENETICS SA, Headquarters, Saint Sulpice, Switzerland.
Felicioni L; Department of Pathology, SS Annunziata Clinical Hospital, Chieti, Italy.
Troncone G; Department of Public Health, University of Naples Federico II, Naples, Italy.
Malapelle U; Department of Public Health, University of Naples Federico II, Naples, Italy.
Scarpa A; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Verona, Italy.; ARC-Net Centre for Applied Research on Cancer, Verona, Italy.
Zamboni G; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Verona, Italy.; Department of Pathology, IRCCS Sacro Cuore - Don Calabria-Negrar, Negrar, Italy.
Calistri D; Laboratory of Biosciences, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Srl, Meldola, Italy.
Barberis M; Unit of Histopathology and Molecular Diagnostics, Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milan, Italy .
Marchetti A; Laboratory of Diagnostic Molecular Oncology, Center for Advanced Studies and Technology (CAST), University of Chieti, Chieti, Italy.; Department of Medical and Oral Sciences and Biotechnologies, University of Chieti, Chieti, Italy.
Pokaż więcej
Źródło :
Journal of clinical pathology [J Clin Pathol] 2021 Oct; Vol. 74 (10), pp. 668-672. Date of Electronic Publication: 2020 Oct 05.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study
MeSH Terms :
Genetic Heterogeneity*
Genetic Testing*
BRCA1 Protein/*genetics
BRCA2 Protein/*genetics
Biomarkers, Tumor/*genetics
Ovarian Neoplasms/*genetics
Computational Biology ; Female ; High-Throughput Nucleotide Sequencing ; Humans ; Italy ; Observer Variation ; Ovarian Neoplasms/pathology ; Predictive Value of Tests ; Reproducibility of Results ; Workflow
Czasopismo naukowe
Tytuł :
The impact of risk reducing bilateral salpingo-oophorectomy on sexual function in BRCA1/2 mutation carriers and women with Lynch syndrome: A systematic review and meta-analysis.
Autorzy :
Kershaw V; Urogynaecology Department, Jessop Wing, Tree Root Walk, Sheffield S10 2SF, United Kingdom. Electronic address: .
Hickey I; Department of Oncology and Metabolism, Sheffield University, Sheffield S10 2SJ, United Kingdom. Electronic address: .
Wyld L; Department of Oncology and Metabolism, Sheffield University, Sheffield S10 2SJ, United Kingdom. Electronic address: .
Jha S; Urogynaecology Department, Jessop Wing, Tree Root Walk, Sheffield S10 2SF, United Kingdom. Electronic address: .
Pokaż więcej
Źródło :
European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2021 Oct; Vol. 265, pp. 7-17. Date of Electronic Publication: 2021 Aug 08.
Typ publikacji :
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms :
Colorectal Neoplasms, Hereditary Nonpolyposis*
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/prevention & control
BRCA1 Protein/genetics ; Female ; Humans ; Mutation ; Retrospective Studies ; Salpingo-oophorectomy
Czasopismo naukowe
Tytuł :
Clinical value of N-acetyl mucinous compounds and lipid peaks in differentiating benign and malignant ovarian mucinous tumors by MR spectroscopy.
Autorzy :
Takeuchi M; Department of Radiology, Tokushima University, 3-18-15, Kuramoto-cho, Tokushima zip: 7708503, Japan. Electronic address: .
Matsuzaki K; Department of Radiological Technology, Tokushima Bunri University, 1314-1, Shido, Sanuki-city, Kagawa zip: 7692193, Japan. Electronic address: .
Harada M; Department of Radiology, Tokushima University, 3-18-15, Kuramoto-cho, Tokushima zip: 7708503, Japan. Electronic address: .
Pokaż więcej
Źródło :
Clinical imaging [Clin Imaging] 2021 Oct; Vol. 78, pp. 127-135. Date of Electronic Publication: 2021 Mar 22.
Typ publikacji :
Journal Article
MeSH Terms :
Magnetic Resonance Imaging*
Ovarian Neoplasms*/diagnostic imaging
Female ; Humans ; Lipids ; Magnetic Resonance Spectroscopy ; Retrospective Studies ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Oncological and Reproductive Outcomes of Cystectomy Compared with Unilateral Salpingo-Oophorectomy as Fertility-Sparing Surgery in Patients with Apparent Early Stage Pure Immature Ovarian Teratomas.
Autorzy :
Wang D; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People's Republic of China.
Zhu S; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People's Republic of China.
Jia C; Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People's Republic of China.
Cao D; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People's Republic of China.
Yang J; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People's Republic of China.
Xiang Y; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People's Republic of China. .
Pokaż więcej
Źródło :
Annals of surgical oncology [Ann Surg Oncol] 2021 Oct; Vol. 28 (11), pp. 6684-6693. Date of Electronic Publication: 2021 Mar 26.
Typ publikacji :
Journal Article
MeSH Terms :
Fertility Preservation*
Ovarian Neoplasms*/pathology
Ovarian Neoplasms*/surgery
Teratoma*/surgery
Cystectomy ; Female ; Humans ; Neoplasm Recurrence, Local/surgery ; Neoplasm Staging ; Ovariectomy ; Pregnancy ; Retrospective Studies ; Salpingo-oophorectomy
Czasopismo naukowe
Tytuł :
The "collateral damage" of the war on COVID-19: impact of the pandemic on the care of epithelial ovarian cancer.
Autorzy :
Goenka L; Department of Medical Oncology, JIPMER, Dhanvantri Nagar, Puducherry, 605006, India.
Anandaradje A; Department of Clinical Pharmacology, JIPMER, Puducherry, India.
Nakka T; Department of Medical Oncology, JIPMER, Dhanvantri Nagar, Puducherry, 605006, India.
Kayal S; Department of Medical Oncology, JIPMER, Dhanvantri Nagar, Puducherry, 605006, India.
Dubashi B; Department of Medical Oncology, JIPMER, Dhanvantri Nagar, Puducherry, 605006, India.
Chaturvedula L; Department of Obstetrics & Gynecology, JIPMER, Puducherry, India.
Veena P; Department of Obstetrics & Gynecology, JIPMER, Puducherry, India.
Durairaj J; Department of Obstetrics & Gynecology, JIPMER, Puducherry, India.
Penumadu P; Department of Surgical Oncology, JIPMER, Puducherry, India.
Ganesan P; Department of Medical Oncology, JIPMER, Dhanvantri Nagar, Puducherry, 605006, India. .
Pokaż więcej
Źródło :
Medical oncology (Northwood, London, England) [Med Oncol] 2021 Sep 28; Vol. 38 (11), pp. 137. Date of Electronic Publication: 2021 Sep 28.
Typ publikacji :
Journal Article
MeSH Terms :
Time-to-Treatment*/trends
COVID-19/*prevention & control
Carcinoma, Ovarian Epithelial/*therapy
Neoadjuvant Therapy/*methods
Ovarian Neoplasms/*therapy
Patient Care/*methods
Aged ; COVID-19/epidemiology ; Carcinoma, Ovarian Epithelial/diagnosis ; Carcinoma, Ovarian Epithelial/epidemiology ; Female ; Humans ; Middle Aged ; Neoadjuvant Therapy/trends ; Ovarian Neoplasms/diagnosis ; Ovarian Neoplasms/epidemiology ; Pandemics ; Patient Care/trends ; Retrospective Studies
Czasopismo naukowe
Tytuł :
[Vincristine inhibits the proliferation of ovarian cancer cells by regulating the demethylation of RASSF2A].
Autorzy :
Wang WX; Department of Gynecology, Xinxiang Central Hospital, the Fourth Affiliated Hospital of Xinxiang Medical College, Xinxiang 453000, China.
Fan WW; Department of Gynecology, Xinxiang Central Hospital, the Fourth Affiliated Hospital of Xinxiang Medical College, Xinxiang 453000, China.
Gao YX; Department of Gynecology, Xinxiang Central Hospital, the Fourth Affiliated Hospital of Xinxiang Medical College, Xinxiang 453000, China.
Dong XC; Department of Gynecology, Xinxiang Central Hospital, the Fourth Affiliated Hospital of Xinxiang Medical College, Xinxiang 453000, China.
Feng XJ; Department of Gynecology, Henan Cancer Hospital, Zhengzhou 450003, China.
Ren J; Department of Gynecology, the Affiliated Hospital of Guizhou Medical University, Guiyang 550025, China.
Pokaż więcej
Źródło :
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2021 Sep 23; Vol. 43 (9), pp. 932-938.
Typ publikacji :
Journal Article
MeSH Terms :
Ovarian Neoplasms*/genetics
Apoptosis ; Cell Line, Tumor ; Cell Proliferation ; Demethylation ; Female ; Humans ; Vincristine/pharmacology
Czasopismo naukowe
Tytuł :
Antibody-functionalized theranostic protein nanoparticles for the synergistic deep red fluorescence imaging and multimodal therapy of ovarian cancer.
Autorzy :
Borlan R; Biomolecular Physics Department, Faculty of Physics, Babes-Bolyai University, Cluj-Napoca, Cluj, Romania. .; Nanobiophotonics and Laser Microspectroscopy Centre, Interdisciplinary Research Institute on Bio-Nano-Sciences, Babes-Bolyai University, Cluj-Napoca, Cluj, Romania. .
Focsan M; Nanobiophotonics and Laser Microspectroscopy Centre, Interdisciplinary Research Institute on Bio-Nano-Sciences, Babes-Bolyai University, Cluj-Napoca, Cluj, Romania. .
Perde-Schrepler M; Department of Radiobiology and Tumor Biology, Oncology Institute Prof. Dr. Ion Chiricuta, Cluj-Napoca, Cluj, Romania.
Soritau O; Department of Radiobiology and Tumor Biology, Oncology Institute Prof. Dr. Ion Chiricuta, Cluj-Napoca, Cluj, Romania.
Campu A; Nanobiophotonics and Laser Microspectroscopy Centre, Interdisciplinary Research Institute on Bio-Nano-Sciences, Babes-Bolyai University, Cluj-Napoca, Cluj, Romania. .
Gaina L; The Research Centre on Fundamental and Applied Heterochemistry, Department of Chemistry, Faculty of Chemistry and Chemical Engineering, Babes-Bolyai University, Cluj-Napoca, Cluj, Romania.
Pall E; Department of Infectious Diseases, University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca, Cluj, Romania.
Pop B; Department of Pathology, Oncology Institute Prof. Dr. Ion Chiricuta, Cluj-Napoca, Cluj, Romania.; Department of Pathology, University of Medicine and Pharmacy Iuliu Haţieganu, Cluj-Napoca, Cluj, Romania.
Baldasici O; Department of Functional Genomics, Proteomics and Experimental Pathology, Oncology Institute Prof. Dr. Ion Chiricuta, Cluj-Napoca, Cluj, Romania.
Gherman C; Department of Functional Genomics, Proteomics and Experimental Pathology, Oncology Institute Prof. Dr Ion Chiricuta, Cluj-Napoca, Cluj, Romania.
Stoia D; Nanobiophotonics and Laser Microspectroscopy Centre, Interdisciplinary Research Institute on Bio-Nano-Sciences, Babes-Bolyai University, Cluj-Napoca, Cluj, Romania. .
Maniu D; Biomolecular Physics Department, Faculty of Physics, Babes-Bolyai University, Cluj-Napoca, Cluj, Romania. .; Nanobiophotonics and Laser Microspectroscopy Centre, Interdisciplinary Research Institute on Bio-Nano-Sciences, Babes-Bolyai University, Cluj-Napoca, Cluj, Romania. .
Astilean S; Biomolecular Physics Department, Faculty of Physics, Babes-Bolyai University, Cluj-Napoca, Cluj, Romania. .; Nanobiophotonics and Laser Microspectroscopy Centre, Interdisciplinary Research Institute on Bio-Nano-Sciences, Babes-Bolyai University, Cluj-Napoca, Cluj, Romania. .
Pokaż więcej
Źródło :
Biomaterials science [Biomater Sci] 2021 Sep 14; Vol. 9 (18), pp. 6183-6202. Date of Electronic Publication: 2021 Sep 14.
Typ publikacji :
Journal Article
MeSH Terms :
Nanoparticles*
Ovarian Neoplasms*/diagnostic imaging
Ovarian Neoplasms*/drug therapy
Animals ; Cell Line, Tumor ; Female ; Humans ; Mice ; Optical Imaging ; Phototherapy ; Precision Medicine ; Theranostic Nanomedicine
Czasopismo naukowe
Tytuł :
LINC00852 promotes the proliferation and invasion of ovarian cancer cells by competitively binding with miR-140-3p to regulate AGTR1 expression.
Autorzy :
Qiao ZW; Department of Gynaecology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Insititute, No.44, Xiaoheyan Road, Shenyang, 110042, Liaoning Province, China.
Jiang Y; Department of Gynaecology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Insititute, No.44, Xiaoheyan Road, Shenyang, 110042, Liaoning Province, China.
Wang L; Department of Gynaecology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Insititute, No.44, Xiaoheyan Road, Shenyang, 110042, Liaoning Province, China.
Wang L; Department of Gynaecology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Insititute, No.44, Xiaoheyan Road, Shenyang, 110042, Liaoning Province, China.
Jiang J; Department of Gynaecology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Insititute, No.44, Xiaoheyan Road, Shenyang, 110042, Liaoning Province, China.
Zhang JR; Department of Gynaecology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Insititute, No.44, Xiaoheyan Road, Shenyang, 110042, Liaoning Province, China. .
Mu P; Department of Gynaecology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Insititute, No.44, Xiaoheyan Road, Shenyang, 110042, Liaoning Province, China. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Sep 08; Vol. 21 (1), pp. 1004. Date of Electronic Publication: 2021 Sep 08.
Typ publikacji :
Journal Article
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*metabolism
MicroRNAs/*genetics
Ovarian Neoplasms/*pathology
RNA, Long Noncoding/*genetics
Receptor, Angiotensin, Type 1/*metabolism
Animals ; Apoptosis ; Biomarkers, Tumor/genetics ; Cell Proliferation ; Female ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/metabolism ; Prognosis ; Receptor, Angiotensin, Type 1/genetics ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Nanog-mediated stem cell properties are critical for MBNL3-associated paclitaxel resistance of ovarian cancer.
Autorzy :
Sun X; Department of Gynecology, Zibo Central Hospital, No. 54 of Gongqingtuan West Road, Zhangdian District, Zibo 255000, Shandong, China.
Diao X; Department of Reproductive Medicine, Binzhou Medical University Hospital, No. 661 of Huanghe 2 Road, Binzhou 256600, Shandong, China.
Zhu X; Department of Gynecology, Zibo Central Hospital, No. 54 of Gongqingtuan West Road, Zhangdian District, Zibo 255000, Shandong, China.
Yin X; Department of Gynecology, Zibo Central Hospital, No. 54 of Gongqingtuan West Road, Zhangdian District, Zibo 255000, Shandong, China.
Cheng G; Department of Gynecology, Zibo Central Hospital, No. 54 of Gongqingtuan West Road, Zhangdian District, Zibo 255000, Shandong, China.
Pokaż więcej
Źródło :
Journal of biochemistry [J Biochem] 2021 Sep 07; Vol. 169 (6), pp. 747-756.
Typ publikacji :
Journal Article
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*metabolism
Nanog Homeobox Protein/*metabolism
Ovarian Neoplasms/*drug therapy
Paclitaxel/*pharmacology
RNA-Binding Proteins/*metabolism
Stem Cells/*pathology
Animals ; Antineoplastic Agents, Phytogenic/pharmacology ; Apoptosis ; Biomarkers, Tumor/genetics ; Cell Proliferation ; Cystadenocarcinoma, Serous/drug therapy ; Cystadenocarcinoma, Serous/metabolism ; Cystadenocarcinoma, Serous/pathology ; Female ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Middle Aged ; Nanog Homeobox Protein/genetics ; Ovarian Neoplasms/metabolism ; Ovarian Neoplasms/pathology ; Prognosis ; RNA-Binding Proteins/genetics ; Stem Cells/metabolism ; Survival Rate ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer.
Autorzy :
Lin J; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.
Liu H; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.
Fukumoto T; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.
Zundell J; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.
Yan Q; Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA, USA.
Tang CA; Center for Translational Research in Hematologic Malignancies, Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston, TX, USA.
Wu S; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.
Zhou W; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.
Guo D; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.
Karakashev S; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.
Hu CA; Center for Translational Research in Hematologic Malignancies, Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston, TX, USA.
Sarma K; Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA, USA.
Kossenkov AV; Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA, USA.
Zhang R; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, USA. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Sep 07; Vol. 12 (1), pp. 5321. Date of Electronic Publication: 2021 Sep 07.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Carcinoma, Ovarian Epithelial/*therapy
Endoribonucleases/*genetics
Ovarian Neoplasms/*therapy
Programmed Cell Death 1 Receptor/*genetics
Protein-Arginine N-Methyltransferases/*genetics
Protein-Serine-Threonine Kinases/*genetics
X-Box Binding Protein 1/*genetics
Animals ; Antibodies, Monoclonal/pharmacology ; Base Sequence ; Benzopyrans/pharmacology ; Carcinoma, Ovarian Epithelial/genetics ; Carcinoma, Ovarian Epithelial/immunology ; Carcinoma, Ovarian Epithelial/pathology ; Cell Line, Tumor ; Endoplasmic Reticulum Stress/drug effects ; Endoribonucleases/antagonists & inhibitors ; Endoribonucleases/immunology ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Hymecromone/analogs & derivatives ; Hymecromone/pharmacology ; Immune Checkpoint Inhibitors ; Mice ; Molecular Targeted Therapy ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/immunology ; Ovarian Neoplasms/pathology ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Programmed Cell Death 1 Receptor/immunology ; Protein Binding ; Protein-Arginine N-Methyltransferases/antagonists & inhibitors ; Protein-Arginine N-Methyltransferases/immunology ; Protein-Serine-Threonine Kinases/antagonists & inhibitors ; Protein-Serine-Threonine Kinases/immunology ; Signal Transduction ; X-Box Binding Protein 1/antagonists & inhibitors ; X-Box Binding Protein 1/immunology ; Xenograft Model Antitumor Assays
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies